2009
DOI: 10.1007/s10461-009-9541-2
|View full text |Cite
|
Sign up to set email alerts
|

Responding to Her Question: A Review of the Influence of Pregnancy on HIV Disease Progression in the Context of Expanded Access to HAART in Sub-Saharan Africa

Abstract: In 2007, sub-Saharan Africa was home to over half of all women living with HIV. The vast majority of these women are of reproductive age, which raises concerns about the high incidence of pregnancy. As access to antiretroviral treatment is rapidly scaled up, two important questions must be answered: (1) Does pregnancy impact HIV disease progression?; (2) Does pregnancy modify the highly active antiretroviral therapy (HAART) response on HIV disease progression? A systematic review of the biomedical literature w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
21
0
1

Year Published

2011
2011
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(24 citation statements)
references
References 22 publications
(26 reference statements)
2
21
0
1
Order By: Relevance
“…ART also enables seropositive women to bear children with far fewer risks to themselves and their children (MacCarthy et al 2009). Accompanying this development in HIV treatment is the advent of new technologies that help serodiscordant couples conceive with minimal or no risk of infecting the HIV-negative partner: periconception ART use for the infected partner and pre-exposure prophylaxis (PrEP) for the uninfected partner combined with treatment for sexually transmitted infections; sex limited to peak fertility; and medical male circumcision and sperm washing so that the semen is removed from the sperm and the woman is artificially inseminated (either through intrauterine insemination or in vitro fertilisation) (Matthews et al 2012, Savasi et al 2013).…”
Section: Introductionmentioning
confidence: 99%
“…ART also enables seropositive women to bear children with far fewer risks to themselves and their children (MacCarthy et al 2009). Accompanying this development in HIV treatment is the advent of new technologies that help serodiscordant couples conceive with minimal or no risk of infecting the HIV-negative partner: periconception ART use for the infected partner and pre-exposure prophylaxis (PrEP) for the uninfected partner combined with treatment for sexually transmitted infections; sex limited to peak fertility; and medical male circumcision and sperm washing so that the semen is removed from the sperm and the woman is artificially inseminated (either through intrauterine insemination or in vitro fertilisation) (Matthews et al 2012, Savasi et al 2013).…”
Section: Introductionmentioning
confidence: 99%
“…However, such research typically concentrates on pregnant women exclusively with primary outcomes that are not focused on maternal health but rather infant or child outcomes. Far less research is performed treating pregnancy either as an exposure (comparing pregnant to non-pregnant women) or as a confounder, modifier, or mediator of main effects [13]. …”
Section: Introductionmentioning
confidence: 99%
“…Biomedical considerations were paramount in providers’ approach to HIV infection and fertility desire; however, these considerations were often not based on accurate knowledge. Despite evidence that pregnancy does not speed progression of HIV disease [2729], - some providers offered this as a reason for not supporting fertility desires of clients. Conception and pregnancy do confer risks of HIV transmission; however, these can be significantly reduced through specific health care interventions [20, 30].…”
Section: Discussionmentioning
confidence: 99%